Clinical Trial Update: Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients [Phase 1]

View source ↗

Summary

Phase 1 study assessed the effect of food on nifurtimox pharmacokinetics in chronic Chagas disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Disease

Drugs mentioned

• Lampit (nifurtimox)

Snippet

Sponsor: Bayer | Conditions: Chagas Disease | Phase 1 | Status: COMPLETED